Perea Francisco, Bernal Mónica, Sánchez-Palencia Abel, Carretero Javier, Torres Cristina, Bayarri Clara, Gómez-Morales Mercedes, Garrido Federico, Ruiz-Cabello Francisco
Servicio de Análisis Clínicos e Inmunología, UGC Laboratorio Clínico; Hospital Universitario Virgen de las Nieves, Granada, Spain.
Servicio de Cirugía Torácica, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Int J Cancer. 2017 Feb 15;140(4):888-899. doi: 10.1002/ijc.30489. Epub 2016 Nov 7.
We wanted to analyze whether tumor HLA class I (HLA-I) expression influences the pattern of the immune cell infiltration and stromal cell reaction in the tumor microenvironment. Tumor tissues obtained from 57 patients diagnosed with lung carcinomas were analyzed for HLA expression and leukocyte infiltration. 28 patients out of the 57 were completely negative for HLA-I expression (49.1%) or showed a selective HLA-A locus downregulation (three patients, 5.2%). In 26 out of 57 tumors (47.8%) we detected a positive HLA-I expression but with a percentage of HLA-I negative cells between 10 and 25%. The HLA-I negative phenotype was produced by a combination of HLA haplotype loss and a transcriptional downregulation of β2-microglobulin (β2-m) and LMP2 and LMP7 antigen presentation machinery genes. The analysis and localization of different immune cell populations revealed the presence of two major and reproducible patterns. One pattern, which we designated "immune-permissive tumor microenvironment (TME)," was characterized by positive tumor HLA-I expression, intratumoral infiltration with cytotoxic T-CD8+ cells, M1-inflammatory type macrophages, and a diffuse pattern of FAP+ cancer-associated fibroblasts. In contrast, another pattern defined as "non-immune-permissive TME" was found in HLA-I negative tumors with strong stromal-matrix interaction, T-CD8+ cells surrounding tumor nests, a dense layer of FAP+ fibroblasts and M2/repair-type macrophages. In conclusion, this study revealed marked differences between HLA class I-positive and negative tumors related to tissue structure, the composition of leukocyte infiltration and stromal response in the tumor microenvironment.
我们想要分析肿瘤人类白细胞抗原I类(HLA-I)表达是否会影响肿瘤微环境中免疫细胞浸润模式和基质细胞反应。对57例诊断为肺癌的患者所获得的肿瘤组织进行HLA表达和白细胞浸润分析。57例患者中有28例HLA-I表达完全阴性(49.1%)或表现为选择性HLA-A位点下调(3例,5.2%)。在57个肿瘤中的26个(47.8%),我们检测到HLA-I表达阳性,但HLA-I阴性细胞百分比在10%至25%之间。HLA-I阴性表型是由HLA单倍型缺失以及β2-微球蛋白(β2-m)、低分子量多肽2(LMP2)和低分子量多肽7(LMP7)抗原呈递机制基因的转录下调共同导致的。不同免疫细胞群体的分析和定位揭示了两种主要且可重复的模式。一种模式,我们称之为“免疫允许性肿瘤微环境(TME)”,其特征为肿瘤HLA-I表达阳性、肿瘤内有细胞毒性T-CD8+细胞浸润、M1炎症型巨噬细胞以及FAP+癌症相关成纤维细胞的弥漫性分布。相比之下,另一种模式定义为“非免疫允许性TME”,见于HLA-I阴性肿瘤,其具有强烈的基质-基质相互作用、肿瘤巢周围的T-CD8+细胞、一层致密的FAP+成纤维细胞以及M2/修复型巨噬细胞。总之,本研究揭示了HLA I类阳性和阴性肿瘤在组织结构、肿瘤微环境中白细胞浸润组成和基质反应方面存在显著差异。